UCL Cancer Institute

London WC1E 6DD

1 studies enrolling now · 10 studies all time

What they study most

Advanced Solid Tumors, Biliary Tract Cancer (BTC), Carcinoma, Non-Small-Cell Lung, Castration-Resistant Prostatic Cancer, Colorectal Cancer (CRC), Diamond-Blackfan Anemia, Diffuse Large B-Cell Lymphoma, Endometrial Cancer, Gastroesophageal Cancer (GC), Glioblastoma Multiforme, Hepatocellular Carcinoma, Hormone Receptor-Positive Breast Cancer

Studies at this site

• Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells — Recruiting now
• A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer — Running, not enrolling
• A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Running, not enrolling
• A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors — Completed
• A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma — Completed
• A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia — Completed
• Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors — Completed
• Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma — Completed
• Multi-Center Study of Iron Overload: Pilot Study — Completed
• Multi-Center Study of Iron Overload: Survey Study (MCSIO) — Completed